{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T10:49:11Z","timestamp":1778323751306,"version":"3.51.4"},"reference-count":79,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Chimeric Antigen Receptor (CAR) T cell therapy represents a groundbreaking advancement in immunotherapy, initially gaining FDA approval for treating hematological malignancies. This therapy has shown promising results in solid tumors, particularly in pediatric brain tumors, which are the leading cause of cancer-related death in children. CAR T cells are engineered to target specific antigens on tumor cells, thereby reducing off-target effects and increasing the cytotoxic impact on cancer cells. Over the years, CAR T cell technology has evolved through five generations, each enhancing the structure, functionality, and safety of these cells. Despite these advancements, the application of CAR T cells in solid tumors, especially within the central nervous system (CNS), faces significant challenges. These include the physical barrier posed by the blood-brain barrier (BBB), the immunosuppressive tumor microenvironment (TME), and the heterogeneity of tumor antigens. The review discusses several promising antigenic targets for CAR T cells in pediatric brain tumors, such as HER2, EphA2, IL-13R\u03b12, and Survivin, which have been explored in recent clinical trials. These trials have shown early promise in improving patient outcomes, though the risks of cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) remain concerns. The future of CAR T cell therapy lies in overcoming these barriers through innovative approaches like \u201cArmored CARs\u201d or TRUCKs, designed to modulate the TME and improve CAR T cell efficacy in solid tumors. Additionally, combination therapies and safety switches in next-generation CAR T cells are being explored to enhance therapeutic potential while minimizing adverse effects.<\/jats:p>","DOI":"10.1177\/10781552251331609","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T18:39:50Z","timestamp":1743273590000},"page":"1150-1158","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Advancements and challenges in CAR T cell therapy for pediatric brain tumors: A review"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9842-6221","authenticated-orcid":false,"given":"Yasmina","family":"Gaoual","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, 10 170 Rabat, Morocco"},{"name":"Specialties Hospital of Rabat, Ibn Sina University Hospital, 10 170 Rabat, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Mahyaoui","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, 10 170 Rabat, Morocco"},{"name":"Specialties Hospital of Rabat, Ibn Sina University Hospital, 10 170 Rabat, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamyae","family":"Yachi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, 10 170 Rabat, Morocco"},{"name":"Children's hospital of Rabat, Ibn Sina University Hospital, 10 170 Rabat, Morocco"},{"name":"Team of analytical chemistry and bromatology, Faculty of Medicine and Pharmacy, Mohammed V University- Rabat, 10 170 Rabat, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha","family":"Bouatia","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, 10 170 Rabat, Morocco"},{"name":"Children's hospital of Rabat, Ibn Sina University Hospital, 10 170 Rabat, Morocco"},{"name":"Team of analytical chemistry and bromatology, Faculty of Medicine and Pharmacy, Mohammed V University- Rabat, 10 170 Rabat, Morocco"},{"name":"Ibn Sina University Hospital Center, 10 170 Rabat, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zineb","family":"Aliat","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, 10 170 Rabat, Morocco"},{"name":"Specialties Hospital of Rabat, Ibn Sina University Hospital, 10 170 Rabat, Morocco"},{"name":"Team of Formulation and Quality Control of Health Products, Faculty of Medicine and Pharmacy, Mohammed V University- Rabat, 10 170 Rabat, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younes","family":"Rahali","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, 10 170 Rabat, Morocco"},{"name":"Specialties Hospital of Rabat, Ibn Sina University Hospital, 10 170 Rabat, Morocco"},{"name":"Ibn Sina University Hospital Center, 10 170 Rabat, Morocco"},{"name":"Team of Formulation and Quality Control of Health Products, Faculty of Medicine and Pharmacy, Mohammed V University- Rabat, 10 170 Rabat, Morocco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2017.07.003"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01850"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0827-2"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-18-0784"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90327-U"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90314-O"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/356607a0"},{"key":"e_1_3_4_9_2","first-page":"4472","article-title":"T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression","volume":"7","author":"June CH","year":"1987","unstructured":"June CH, Ledbetter JA, Gillespie MM, et al. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol 1987; 7: 4472\u20134481.","journal-title":"Mol Cell Biol"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.1.165"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403302"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.83"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.09.009"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144787"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-01-761320"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2015.1046430"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12125"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4478"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13478"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.24.10024"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.2.720"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00360"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.6.2791"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2009.122"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4597"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1363139"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-019-2118-z"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.34213"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-013-9608-0"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0205-x"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.20517\/2394-4722.2015.78"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12773"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2012.04.009"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1159\/000071316"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-011-0922-z"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-380916-2.00008-5"},{"key":"e_1_3_4_37_2","first-page":"3","article-title":"Immunotherapy targets in pediatric cancer","volume":"2","author":"Orentas RJ","year":"2012","unstructured":"Orentas RJ, Lee DW, Mackall C. Immunotherapy targets in pediatric cancer. Front Oncol 2012; 2: 3.","journal-title":"Front Oncol"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.3359"},{"key":"e_1_3_4_40_2","first-page":"20","article-title":"CBTRUS Statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015","author":"Ostrom QT","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, et al. CBTRUS Statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015. Neuro Oncol 2018: 20\u201386. doi: https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro Oncol"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-012-0998-x"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-008-9534-4"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-011-0677-3"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00495"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noaa278"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01404-8"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0006-x"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04489-4"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02875-1"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.4508"},{"key":"e_1_3_4_53_2","unstructured":"ClinicalTrials.gov. HER2-Specific CAR T Cells in Pediatric Patients with HER2-Positive CNS Tumors. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCTXXXXXXX."},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.31.15_suppl.10007"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.567"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01529"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.229781"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2019.01.005"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.7150\/thno.76854"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2360"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111781"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00550"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.07.005"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01371"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aay6017"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1042\/BST20150291"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01892"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2019.08.002"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04248-y"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0426"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-1037-z"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.11.005"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01800-8"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.003"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70082-8"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1757360"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-020-0189-4"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14081630"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2029070"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552251331609","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552251331609","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552251331609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:31:00Z","timestamp":1777689060000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552251331609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":79,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1177\/10781552251331609"],"URL":"https:\/\/doi.org\/10.1177\/10781552251331609","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]}}}